Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine M Kelly

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Irish Journal of Medical Science|February 10, 2022
Using menopausal hormone therapy after a cancer diagnosis in IrelandFionán Donohoe, Yvonne O'Meara, Aidin Roberts, et al.
Contemporary Clinical Trials Communications|December 6, 2021
The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer - Trial protocol of a phase II studyFionán Donohoe, Yvonne O'Meara, Aidin Roberts, et al.
Circulation. Heart Failure|January 22, 2021
Subclinical Myocarditis After Combination Immune Checkpoint Inhibitor TherapyGerard T Giblin, Colum Dennehy, Hannah Featherstone, et al.
Journal of Clinical Microbiology|February 15, 2013
"Candidatus Mycoplasma haemomacaque" and Bartonella quintana bacteremia in cynomolgus monkeysRicardo G Maggi, Patricia E Mascarelli, Nandhakumar Balakrishnan, et al.
Oncology Research and Treatment|December 23, 2014
Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanomaGrainne M O'Kane, Tomas G Lyons, Gabrielle C Colleran, et al.
The Oncologist|March 16, 2012
Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancerCatherine M Kelly, Philip S Bernard, Savitri Krishnamurthy, et al.
Acta Medica Okayama|October 23, 2015
Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer: NACED-Randomized Multicenter Phase II TrialKumi Sugiu, Takayuki Iwamoto, Catherine M Kelly, et al.
The American Journal of Hospice & Palliative Care|January 13, 2021
A Multicenter Retrospective Review of Systemic Anti-Cancer Treatment and Palliative Care Provided to Solid Tumor Oncology Patients in the 12 Weeks Preceding Death in IrelandVictoria Mallett, Anna Linehan, Orla Burke, et al.
Cancers|March 28, 2024
Multimodal, Technology-Assisted Intervention for the Management of Menopause after Cancer Improves Cancer-Related Quality of Life-Results from the Menopause after Cancer (Mac) StudyFionán Donohoe, Yvonne O'Meara, Aidin Roberts, et al.
Irish Journal of Medical Science|May 17, 2018
Where youth matters-clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancerMegan Greally, Jennifer Kielty, Geoffrey A Watson, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Irish Journal of Medical Science|February 10, 2022
Using menopausal hormone therapy after a cancer diagnosis in IrelandFionán Donohoe, Yvonne O'Meara, Aidin Roberts, et al.
Contemporary Clinical Trials Communications|December 6, 2021
The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer - Trial protocol of a phase II studyFionán Donohoe, Yvonne O'Meara, Aidin Roberts, et al.
Circulation. Heart Failure|January 22, 2021
Subclinical Myocarditis After Combination Immune Checkpoint Inhibitor TherapyGerard T Giblin, Colum Dennehy, Hannah Featherstone, et al.
Journal of Clinical Microbiology|February 15, 2013
"Candidatus Mycoplasma haemomacaque" and Bartonella quintana bacteremia in cynomolgus monkeysRicardo G Maggi, Patricia E Mascarelli, Nandhakumar Balakrishnan, et al.
Oncology Research and Treatment|December 23, 2014
Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanomaGrainne M O'Kane, Tomas G Lyons, Gabrielle C Colleran, et al.
The Oncologist|March 16, 2012
Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancerCatherine M Kelly, Philip S Bernard, Savitri Krishnamurthy, et al.
Acta Medica Okayama|October 23, 2015
Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer: NACED-Randomized Multicenter Phase II TrialKumi Sugiu, Takayuki Iwamoto, Catherine M Kelly, et al.
The American Journal of Hospice & Palliative Care|January 13, 2021
A Multicenter Retrospective Review of Systemic Anti-Cancer Treatment and Palliative Care Provided to Solid Tumor Oncology Patients in the 12 Weeks Preceding Death in IrelandVictoria Mallett, Anna Linehan, Orla Burke, et al.
Cancers|March 28, 2024
Multimodal, Technology-Assisted Intervention for the Management of Menopause after Cancer Improves Cancer-Related Quality of Life-Results from the Menopause after Cancer (Mac) StudyFionán Donohoe, Yvonne O'Meara, Aidin Roberts, et al.
Irish Journal of Medical Science|May 17, 2018
Where youth matters-clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancerMegan Greally, Jennifer Kielty, Geoffrey A Watson, et al.
Pageof 7